We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Cites Myerson for MDR Deficiencies, CAPA Lapses
FDA Cites Myerson for MDR Deficiencies, CAPA Lapses
Failure to file a medical device report within 30 days and to establish adequate procedures for corrective and preventive actions (CAPAs) were among the quality system deviations the FDA discovered during a March 16 to May 4 inspection of Myerson’s Chicago, Illinois facility.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor